AGP Ltd (AGPL)

Currency in PKR
189.83
-2.19(-1.14%)
Closed·
AGPL Scorecard
Full Analysis
Trading at a low P/E ratio relative to near-term earnings growth
Earnings results expected today
AGPL is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
189.00192.00
52 wk Range
97.00220.02
Key Statistics
Bid/Ask
189.50 / 189.83
Prev. Close
189.83
Open
192
Day's Range
189-192
52 wk Range
97-220.02
Volume
97.24K
Average Volume (3m)
365.59K
1-Year Change
91.79%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
AGPL Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
230.00
Upside
+21.16%
Members' Sentiments
Bearish
Bullish
ProTips
Valuation implies a strong free cash flow yield

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

AGP Ltd Company Profile

AGP Limited manufactures, sells, wholesales, distributes, exports, imports, markets, deals in pharmaceutical and healthcare products in Pakistan and Afghanistan. The company offers products in the areas of aminoglycosides, angiotensin II antagonist, anti-epileptics, anti-gout, anti-infective antidiarrheal, anti-inflammatory enzyme, antidiarrheal microorganisms, antifibrinolytic, antihistamines systemic, antileuk anti-ashtm sys, antineoplastic agent, anti-obesity, antirheumatic non-steroid, antispasmodic and anticholinergic plain, atypical antipsychotics, biguanide and S-urea combs, bile stone therapy, calcium, calcium channel blocker, cephalosporins oral and inject, DPP-IV Inh and biguanide comb, DPP-IV Inh A-diab plain, expectorants, eye tonics and eye vitamins, fluoroquinolones, glitazone and S-urea combs, glitazone A-diabs plain, glitazone and biguanide combinations, hepatitis C antivirals, iron combination products, iron plain, lipid modifying agents combinations, menthae piperitae aetheroleum, muscle relaxants central, narcotic analgesic, and non-narcotic analgesic. It provides narcotic analgesic, non-narcotic analgesics, nucleoside reverse transcriptase inhibitors, Oth anti-anaem folic acid, other musculoskeletal products, other stomach disorder products, proton pump inhibitor, psycholeptic antidepressant, SGLT2 inhibitors antidiabetic and biguanide, sitagliptin, SSRI antidepressants, sulphonylurea, systemic vasoprotectives, tonic, topical antihaemorrhoidal, urinary anti-infectives, urinary incontinence prd, vitamin B12, vitamin B12 plain, vitamin C combinations, vitamin D3, and xanthine-systemic products. The company was founded in 1989 and is headquartered in Karachi, Pakistan. AGP Limited operates as a subsidiary of Merck Sharp & Dohme of Pakistan Limited.

Employees
2143
Market
Pakistan

Compare AGPL to Peers and Sector

Metrics to compare
AGPL
Peers
Sector
Relationship
P/E Ratio
17.0x22.4x−0.6x
PEG Ratio
0.180.050.00
Price/Book
3.7x2.5x2.6x
Price / LTM Sales
2.0x2.0x3.3x
Upside (Analyst Target)
31.7%20.7%39.1%
Fair Value Upside
Unlock5.8%5.3%Unlock

Analyst Ratings

2 Buy
1 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 230.00
(+21.16% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 11.15%
Dividend Yield
3.16%
Industry Median 1.88%
Annualised payout
6.00
Paid unevenly
5-Years Growth
+4.24%
Growth Streak

Earnings

Latest Release
Apr 30, 2025
EPS / Forecast
3.04 / --
Revenue / Forecast
7.16B / --
EPS Revisions
Last 90 days

AGPL Income Statement

People Also Watch

FAQ

What Stock Exchange Does AGP Trade On?

AGP is listed and trades on the Karachi Stock Exchange stock exchange.

What Is the Stock Symbol for AGP?

The stock symbol for AGP is "AGPL."

What Is the AGP Market Cap?

As of today, AGP market cap is 53.15B.

What Is AGP's Earnings Per Share (TTM)?

The AGP EPS (TTM) is 11.15.

When Is the Next AGP Earnings Date?

AGP will release its next earnings report on 02 Sept 2025.

From a Technical Analysis Perspective, Is AGPL a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has AGP Stock Split?

AGP has split 0 times.

How Many Employees Does AGP Have?

AGP has 2143 employees.

What is the current trading status of AGP (AGPL)?

As of 03 Sept 2025, AGP (AGPL) is trading at a price of 189.83, with a previous close of 189.83. The stock has fluctuated within a day range of 189.00 to 192.00, while its 52-week range spans from 97.00 to 220.02.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.